The CTI segment is an optional segment that contains information to identify the clinical trial, phase and time point with which an order or result is associated.
Figure 7-17. CTI attributes
SEQ |
LEN |
DT |
OPT |
RP/# |
TBL# |
ITEM# |
ELEMENT NAME |
1 |
60 |
CE |
R |
01058 |
Sponsor Study Identifier |
||
2 |
60 |
CE |
C |
01051 |
Study Phase Identifier |
||
3 |
60 |
CE |
O |
01055 |
Study Scheduled Time Point |
7.7.4.0 CTI field definitions
Components: <identifier (ST)> ^ <text (ST)> ^ <name of coding system (ST)> ^ <alternate identifier (ST)> ^ <alternate text (ST)> ^ <name of alternate coding system (ST)>
Definition: This field contains the universal identifier for the clinical trial. The coding system is as described in CSR-1-study ID.
Components: <identifier (ST)> ^ <text (ST)> ^ <name of coding system (ST)> ^ <alternate identifier (ST)> ^ <alternate text (ST)> ^ <name of alternate coding system (ST)>
Definition: This field identifies the phase of the study that a patient has entered. See CSP-1-study phase ID for details of coding systems.
Components: <identifier (ST)> ^ <text (ST)> ^ <name of coding system (ST)> ^ <alternate identifier (ST)> ^ <alternate text (ST)> ^ <name of alternate coding system (ST)>
Definition: This field identifies a time point in the clinical trial phase. CTI-2-study phase identifier must be valued if CTI-3-study scheduled time point is valued. Should correspond to CSS-1-scheduled time point.